Climb Bio Inc (CLYM) — Financial Flexibility Index
Climb Bio Inc (CLYM) has a Financial Flexibility Index of -1.52x as of June 2026. Free cash flow of $-10.29 Million (operating CF $-10.55 Million minus capex $260.00K) represents -2% of total liabilities ($6.75 Million). Check Climb Bio Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Climb Bio Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Climb Bio Inc across 7 annual periods. For the full cash flow conversion analysis, see Climb Bio Inc (CLYM) cash flow conversion.
Annual Financial Flexibility Index for Climb Bio Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Climb Bio Inc. Explore Climb Bio Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -7.45x | $-54.17 Million | $-54.36 Million | $7.27 Million | ▼ -154.1% |
| 2024 | -2.93x | $-15.56 Million | $-15.56 Million | $5.31 Million | ▲ +59.1% |
| 2023 | -7.18x | $-20.60 Million | $-20.60 Million | $2.87 Million | ▼ -20.6% |
| 2022 | -5.95x | $-37.37 Million | $-37.37 Million | $6.28 Million | ▲ +0.3% |
| 2021 | -5.97x | $-36.07 Million | $-36.07 Million | $6.04 Million | ▼ -29.8% |
| 2020 | -4.60x | $-14.10 Million | $-14.10 Million | $3.06 Million | ▲ +28.0% |
| 2019 | -6.40x | $-5.01 Million | $-5.01 Million | $783.00K | — |